5PSQ-091 Dalbavancin administration in outpatients to reduce hospital stay in selected patients

Autor:	C Montero-Vilchez, MP Aznarte-Padial, A Espinosa-Rodriguez, MR Cantudo Cuenca
Rok vydání:	2022
Zdroj:	Section 5: Patient safety and quality assurance.
DOI:	10.1136/ejhpharm-2022-eahp.312
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9e1877106f8abeccbc1d11b52d0bef6b https://doi.org/10.1136/ejhpharm-2022-eahp.312 Zobrazit plný text záznamu